1396P Phase II Study of AZD4635 in Combination with Durvalumab or Oleclumab in Patients (pts) with Metastatic Castrate-Resistant Prostate Cancer (Mcrpc)
Annals of Oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2022)